BGI

华大基因

Founded in 1999, a leading global genomics research institution that employs techniques such as gene testing, mass spectrometry, and bioinformatics analysis to provide research services and comprehensive solutions for precision medical testing. The institution has established a service network that covers the entire nation and reaches globally.

BGI (Beijing Genomics Institute) primarily engages in research services and comprehensive solutions for precision medical testing by utilizing techniques including gene testing, mass spectrometry, and bioinformatics analysis for research institutions, enterprises, medical institutions, and public health organizations.

Guided by the vision of “Advancing genomics for a better life,” BGI aims to accelerate progress in life science research, apply big data in life sciences, and enhance global healthcare. Based on the achievements in genomics research and the application of precision testing technology in public health, the institute strives to accelerate technological innovation, reduce birth defects, strengthen cancer prevention and control, mitigate the impact of major diseases on humanity, achieve precision cures for infections, and comprehensively contribute to precision medicine.

Leveraging advanced platforms for biological information research, transformation, and application, along with hundreds of high-throughput sequencers, mass spectrometers, and high-performance computers, BGI provides robust support for data generation, storage, and analysis.

With its headquarters in Shenzhen, China, BGI has branches and medical testing facilities in major cities within China, including Beijing, Tianjin, Wuhan, Shanghai, Guangzhou, and Hong Kong. Additionally, BGI has established overseas centers and core laboratories in Europe, the Americas, and the Asia-Pacific region, forming a network layout that covers the entire nation and extends globally.

BGI mainly serves research institutions, independent medical testing labs, pharmaceutical companies, and medical and health institutions at various levels in China and internationally. The institution’s business has expanded to cover over 100 countries and regions globally, including more than 2,000 research institutions and over 2,300 medical institutions within China, including over 300 top-tier hospitals. BGI has also collaborated with over 3,000 overseas medical and research institutions in regions such as Europe, the Americas, and the Asia-Pacific.

Best-selling Products from the BGI Brand：